Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I am starting to feel that I am in a big crap game
hoping for a hard eight that pays 9 for 1 !
Don Robbins et al have control of the dice.
I have my money up there while he rolling his numbers
No hard eight yet! He is rolling a lot craps 2's,3's 12''s
Still no luck yet on the hard eight or numbers.
Don still has control of the dice I still don;t know if he is going roll a hard eight or give me a heart ache!
go Don show us a hard eight!
regards,
bbhuey
According to my analysis software it says that
the trend is driven by strong forces and insiders.
I think the company is selling shares to raise funds.
Since last Friday somebody with a big supply of shares
has been seling in 20,000 to 40,000 share batches
The Lajolla Financing promissory notes done 11/07
when the stock was $.52 or so had a provision in it
that the stock cannot be below $.38 or $.25 in which case
CTGI has the option to buy back the promissory note at
118 % of value.
The 8 K that was filed only that Lajolla gets the shares at their election at 80% of the average value at the time of election or CTGI pays them back at 118% of value.
It is unclear as to what is happening but it could be the company selling shares to avoid significant dilution
on these promissory notes.
Anybody have any clues?
Regards
bbhuey
Jagman,
Do you know how hard it is to get busy surgeons away and together to train on this technology in one place,deal with their wives and families and to get Medicare and insurance reimbursements for this technology?
This takes extensive planning at the right venues and a lot of resources
It is not like selling apples and oranges or pouring a cup of coffee.
Regards,
bbhuey .
oranges
I remember reading articles about how IBM started under
T J watson that was formerly a meat scale company that bought out a punced card company and bet the entire future of the company on System 360.
The development of the system cost millions to the point
when the payroll came around they could only pay in IBM
stock.
The IBM employees that sold their stock for whatever they could get for it before it became known got peanuts those
employees that chose to hold onto their shares sawe the stock
price of their IBM shares soar and split many times
to a market price of over $600 per share.
later on those original employees became millionaires and used to the money to benefit their families and set up Foundations to donate the money to certain charities and public works.
Those emplloyees that sold their shares chose to stay at
IBM and retired with nothing more than thier retirement
and whatever IBM stock they bought at a discount in the Employees stock purchase plan but missed the real rise
in the value of the stock upon the introduction of IBM system
360.
Shareholders of CTGI have a choice they can hold until
things develop or they can sell for pennies and go on
to whatever they consider will generate them a better return
It is a question of faith in the leaders that manage this company
In light of this financial environment,bailouts,ponzi schemes
and etc. it is understandable people are nervous about their money and will redeem their shares at a moments notice.
Many stock on the OTCBB or pinkheets at these prices in the pennies do not work out for whatever reasons that cuts off their potential,others turn out to be a golden parachute
for their executives and others may turn out to be frauds
Back then they had major competitors that were way ahead of them like Sperry Univac,RCA,Unisys and etc. in which they
chose not to disclose what they were working on or how they
were going to sell or market their system.These compnaies like
Johnson and Johnson and Baxter have hundreds of millions behind them to stay in business.
Since noone had the system they had then IBM chose not to sell their units but to lease them out.This assured IBM of steady
uninterrupted income and no one being able to take their machines apart to reverse engineer a copy of a better machine without their permission.
IBM did not give minute by minute updates of what they were doing and how they were going to market their computers
in advance of introduction for fear of competitive interferrence by the other companies
If IBM had done that many years ago it would have given its much bigger competitors and advantage as to how to stop them
from picking up any of their market share
CTGI has the potential to pick up market share in a market
that is growing at a 16% annual compounded growth rate
that can run into the billions of dollars in the future
Any small perecntage of this market is a major event
for such a small company as CTGI
Regards,
bbhuey
Ctgi has a present market cap of about $7M
this consists of 86% of LTC and worldwide patents
and exclusive worldwide marketing rights
and its co2 technolgy ts y.
I know there are property valuation consultants
that can put values on such intangibles such as software
goodwill and patents. I know I dealt with them many years ago
when a compnay I was working for acquireed a compnay picture telepehone in 1982 and didn;t use the technolgy.
If we try to break down a valuation and assign dollar values
to each I am sure that we will equal or exceed the present
stock price of $.17 with 41 Million shares outstanding
and debt outstanding of about $6-7 Million
Lets us see how much of a going conern value there would be
estimated for each item
Surgical company
1. 13 filed U.S. and European patents n
2. Entire in house engineering design team for new
disposable instruments
3. Approved VAD generator in U.S. and EU
4. Approved 2 disposable surgical instruments
in the U.S. and EU
5. Company staff Manufacuring,Administration and Sales
Generally just the FDA and EU approvals alone depending
upon the product can be worth in a range from Millions to hundreds of Millions of Dollars.
I hope it is the later.
The Co2 technology.
1.Exclusive world wide rights to carbon recapture technology
2.Product development for co2 coal a fired
power plants carbon recapture
3.Carbon credit potential
Right now we have a zero value for this portion of the compnay
Does anyone have any ideas what the valuations would be?
This is like pin the value onto the tail of the donkey here..
Just some food for thought even though the action of the stock
lately has been quite disappoitning.
Don's team has been around and been there done that.
All the more reason to be patient and wait for
some good news because Rome wasn't bulit in a day
even though building seems to be on fire and the Bears have
landed and are taking everything over
Regards,
BBhuey
Well I finally got my 10,000 shares today missed missed
last low of $.14 but they wouldn't let me have any.
regards,
bbhuey
will buy even more
Joe,
It is nice to see you here again and wish you godspeed on
your mission in the Philipines.
I don;t think that people realize the extent of the
wound closure market that we are in that is over $750M
and is expected grow at a 16% annual compunded growth rate
to exceed $8.4 Billion by 2015 according to Global Industry
Analysts .
For details of this report see www.strategyr.com/Surgical Incision Closures Market Report aspo
I am sure DOn has his hands full to work on details of the
expected lanuch.
This requires a lot of resources to get into position
funding,training,postioning,insuranceand medicare
reimbbursments ,hospital and surgeon acceptance and etc.
Don is staying the course otherwise he would have sold out to a major like OMRIX did in November for $438Million with a deal they cannot refuse by a buyout by Johnson and Johnson for their fibrin patch.
I think if anyone has gotten any information on when the company will be starting training it can give us a clue
as to what is happening here since this is generally done months in advance before a launch or rollout of such a product it would help?
Regards,
BBhuey.
at et
Can anyone tell whether it was an institution that was selling
selling last week?
I think it may be the 11/17/08 financing shown on the the 8K
that was filed for the $125K CTGI got in which the stock
was not to go below $.25 or $.38 in which case CTGI has the option of paying 118% of the value
If this is the case that the CTGI has to sell stock to meet this cash demand wouldn't CTGI be required to make a filing to to le us know what is happening?
Anybody HAVE ANY THOUGHTS ON THIS?
REGARDS
BBHUEY
*K ink
WELL I HAVE BEEN GETTING DISAPPOINTED ALSO, WITH THIS BACK
AND FORTH AND THIS SLOW TREND DOWN.
COULD LAJOLLA BEING PLAYING GAMES WITH US ON THE LAST ROUND OF FINANCING
LAST NOVEMBER AND WE HAVE TO COUNT
3-6 MONTHS BEFORE THEY GET THIER FIRST DOLLAR FROM THEM.
DR MUST BE UNDER A GREAT DEAL OF PRESSURE TO MAKE SOMETHING
HAPPEN WITH THE CSMG STOCK OTHERWISE IT COLD RESULT IN AN
EXCESS OF DILUTION ON THE CSMG STOCK
NO WORD YET ON THE IPO FOR LTC YET AND FUNDS FOR THEM
IT IS A BAD ENVIRONMENT FOR CREDITY AND EQUITY FINANCING
WITH THE BANKS STILL REPORTING BIG LOSSES EVEN AFTER ALL
OF THE BAILOUT MONEY.
COURTESY OF UNCLE SAM AND THE TAXPAYER.
OH WELL,i DON'T KNOW WHAT IT WILL TAKE TO TURN THE PERMA
BEARS POSITIVE OR BULLISH
ANYWAY CTGI SHAREHOLDERS ARE DUE
SO I PUT IN AN ORDER FOR 8,000 SHARES TO HELP THINGS OUTING
LAST YEAR WAS THE YEAR OF THE RAT AND IT WAS RATTY YEAREYAR.
ON 1/26 WILL START THE YEAR OF THE OX AN EARTH SIGN AND SO IS BARACK OBAMA .
COME ON DON LETS ROLL!
REGARDS,
BBHUEY
.
Thanks Airdale, it was very informative.
Hopefully it will ease our barrier to entry in a big market.
where loss of blood and blood transfusions are issues that
fall into the strengths of the LTC BIOFUSE TECHNOLOGY .
nt t.
Regards,
bbhuey.
See my Jan 11 post.
On Novemeber 11,2008, Johnson and Johnson bought OMRIX for $438 M in cash when they got their FDA fibrin patch approval
in May 2008.
IPO fund raising for 2008 has gotten cut in half and withdrawn
in this bad financial market.
According to my research ,CTGI is missing a big market in Japan where there is a highly emotive feeling against
blood transfusions during surgery.
A joint venture with a Japanese company would do wonders for
the price of our stock.
Only thing is I do not know whether LTC has patents
filed and approved for Japan and whether FDA or EU aaprovals
would cover Japan or whether it would require some other filing.
Does anybody know if we have filed Japanese patents
or FDa filings there?
Regards,
bbhuey
P.S. There is an old farm saying in winter when you
see barren land you don't know what can be planted
unless you have the patience to wait for the harvest.
Glad to see you here again Joe. I needed some confirmation
on some of my posts in the potential of the wound closure market that is growing at a double digit compounded annual
growth whereby surgeons concerns for patient morbidity.
Best Regards,
BBhuey
Male,
I am glad you liked one of my posts!
Regards,
BBhuey
Male,
Sorry for the typo,Yes I mean Ltc's
regards,
bbhuey
LYC's bipolar foreceps can be used as an alternative to
mechanical clamping (lips or staples) and suturing
and used on veins and arteries.
J&J ,Ethicon unit divisions report for 2007 shows that worldwide sales grew 6% and the U.S. up 7% and outside the
U.S grew 5%. with solid growth in sutures and double digit
growth in hemostats and mesh products were a growth contributor during the quarter
In the January issue of Medmarkets with excerpts from
"Worldwide Surgical Sealnats,Glues and Wound Closure,
2007-2011,Report #S145
"The market for surgical sealants is expected to grow double digits over the next 5 yearsas aging populations drive increases in caseloads.In addition less morbidity and better outcomes are seen with the latest fibfin sealants,high strength glues and adhesion prevention products ,thus spurring
increased adoption of these technolgies over traditional wound closure methods."
"Some leading companies in the wound closure market established their leadership positions when the market
consisted exclusively of sutures ,staples,and tapes;
others are new entrants based on expertise in such areas
such as adhesives.While fibrin sealant market is dominated
by Baxter Healthcare and CSL Behring,the high-strength glue
segment is led by U.S.Surgical (now part of Covidien),Ethicon,
and Aesculap(a B.Braun company).Key players in the adhesion prevention products market are Ethicon,U.S. Surgical and Genzyme."
"The commerical importance of wound closure and adhesion
prevention products is directly linked to clinical need
which is reflected in the numbers of procedures that can benefit from imporved wound closure and adhesion prevention
technology."
"Approximtely 10 Million cardiovascular procedures in the U.S. have the potential to benefit from improved hemostsis.
In an estimated 1.5Million procedures ,these products can make a major contribution in the work of the surgeon in carrying out a safe procedure with minimal risk from blood transfusion
and complications assciated with loss of blood."
" There are over 9 Million musculeoskeletal operations worldwide(approximately 4 Million involve minimally invasvie
arthroscopy or are closed fractures".
"Gynecological and urological procedures include transurethral
prostrate resections,bladder surgery,prostratecutomy,hysterectomy,
and srugical resection of adhesions,as well as caesarean
sections.Hemostasis and sealing in these procedures is critical to prevent complications that can result in excessive
bleeding.Neurosurgery (4 Million procedures in the U.S.) is highly vulnerable to the effects associated with healing:
inflammation,angiogenesis,and generation of fibrous tissue-
all attributes of normal tissue repair-cause problems for -neural tissue.
Effective hemostasis and sealing of blood can avoid these traumatic effects and are vital to morbidity.
Most traumatic wounds offer potential to be appropriately
treated with hemostats,sealants and glues.Many lacerations can be treated with high strength glue products,this would avoid
the secondary visist to the medical center for removal of sutures and associated costs.For example ,conservative estimates of ER costs for closure of a small bleeding
trauma laceration with sutures (including local anesthesia
antibiotic cream and suture removal kit) are approximately $75
before labor and time included.
Further,in U.S.acute care hospitals,5-10% of patients develop
hospital acquired infections,many of them wounds.The cost per wound ranges from $3,000-$27,000."
"One market that these products are of special interest
is in Japan where loss of blood and avoidance of transfusion
are extremely emotive issues."
It is hard to believe that LTC's Biofuse technology
will not capture a small percentage of the market
in clips and clamps and in artery duct and vessel sealing .
I notice that in November 2008 quickly bought out OMRIX
for $438 Million to acquire their fibrin seal technology
I don't think Don,Frank, and s been
consultant to the majors like Johnson and Johnson
are ready to sell for $.25 or have given up yet. .
Regards,
BBHUEY
UNSA
I noticed Beacon Equity Research is following CSMG
and has a comment on their 2009 launch.
that was issued on 12/10-/08
Also GII express-Market Research portal
has a product pipeline analysis report on CSMG dated
8/28/08 for USD $750
They cover the Asian and Japanese markets and international markets
The world is waiting for world wide launch in 2009
regards,
bbhuey
I recall years ago I invested in a stock like this and they
got FDA approval for their drug and the stock dropped from
$8 to $2 and then went back to $8 and back down to $3.
I was so frustrated that I got angry and took the loss at $3
and missed the pop back up to $5 or $6
The pharmaeceutical stock had more $92M worth of assets
and over $219 M in liablities as it does today and operates at a loss
In this case CTGI has little assets and over $6 M plus in liablities
I compared the charts of both of them CTGI and IDEV
and they look like they are brothers and follow the same chart
pattern
Well the motto of the story is don't the stock action
to frustrate you from reaping a harvest.
Regards,
bbhuey
male
Happy New Year to you also.
As Fox News would say we need fair and balanced reporting and factual contributors observing industry trends in this market place for this product eo
We need the pros and cons about this stock since the
company has gotten FDA and EU approval the stock has
gone the other way.
We need to understand reasons why we are languishing at $.30 per share when prior
to FDA approval we were over $2.
The company has a great product but has been relatively slow
in getting this across the plate in timely execution and it has been 5 months since approvals.
Bases are are loaded now they have FDA and EU approval
approval,manufacturing,inventory build up and a international sales manager to handle the distribution channels and
joint ventures
We need lift off now in the form of financing,distribution sales and market awareness at the investor level,surgeon level
and patient level
Thus far,the company has fell far short in acheiving these goals by playing this close to the vest
I am sure this has caused the weak hands to sell their stock
You tend to perceive as my questions as negative when
I ask for opinions about where company is headed since their approvals and any new developments that will affect the price of this stock
They have not gained any traction in sales or a joint venture meanwhile this lack of progress has resulted in selling and the stock being where it is
Hopefully the time is now at hand the first quarter of 2009
that the company has promised to launch and hopefully they
have the wherewithall to execute.
It is now show me time,if not the market opportunity may drift awayand go to the majors or some other well financed company and we will stay where we are now
bbhuey
w
PatD
did you find out anything from Medmarkets Diligence as
it relates to CSMG under index number 4.32 report S175
called Worldwide Sealnts ,glues,Wound closure and Anti-Adhesive markets for 2009-2013.
I called Patrick and he told me it was a profile of the company and that there were two mentions of CSMG
as being a new part of an expanded of list of companies
in this market and the profile
Then I noticed in their newsletter for N November November 2008 Med mrt -ups
they mention a minimally invasive RF Tissue welding technology
for use in lung resection and lung biopsy
I couldn't find out whether this was CSMG or another company
Does anybody know anything about this
Happy New Year
bbhuey
s
I was doing some DD on our CTGI instruments in Russian
and saw a picture in which they had 19 tools including
the generator
The development of the two present approved tools from he universal device to provide more flexibility
to make the procedure automatic has been achieved more error free as compared to other systems.
As a result of the speed in which vessels can be sealed
I think that this may also lead to less of a use for hemostats
and clamps but I am not sure and other associated problems.
Wwhere is Joe Synder can he answer
this?
I looked at some companies such as Starion that use low
thermal energy and pressure to do their electo surgery but can't help to think about what can happen even using low thermal energy.
If body temeperature is brought do t down by anesthesia that there can still be burning or tissue damage or lack
of sealing or sticking as a result of this.
My DD shows that radiopfrequency instruments have a 9% market share and that there is an 18% compounded annual growth rate
for radioffrequency instruments
General and specialty procedures within conventional
electrorsouurgery sector total about 17 Million procedures annually in e U.S. and expected to grow to 20 Million n
by 2010
By 2010 ,Laparscopic and medical devices are expected to grow to $18.5Billion
The big majors dominates this space like Johnson and Johnson,Tyco Health care and Baxter otherwise they will
acquire what they don't have
Gyrus acquired ACMI in 2005-Thermal therapy
Olympus acquired GYRUS in 2007- radiofrequency
In May 2008,OMrix got FDA approval for their Fibrin patch and got acquired by Johnson and Johnson for $483M in November
Since 2004 this industry has been consolidated by over
18 mergers and acquisitions since 2004
So if CTGI is eventually successful we may become takeover
bait
I don't know why we are at $.30 with FDA and EU approval
even though we have no revenues the financial environment
doesn't help either
Happy New Year CTGI Longs
All the Best
bbhuey
PATD did you get the latest report on the wounhdcare for 2009-2915
If not does anybody else anything about this?
Happy Hoiidays
bbhuey
My nickel stock dropped back yesterday and today
so I guess its not yet the time for CTGI to move
In this lousy market I wonder when CTGI will file
their S-1 for the LTC IPO ?
Anybody see any preliminary S-1 filings yet?
I noticed that originally s to help with
some bridge or mezzanine financing for CTGI but instead
went with La Jolla timed to take affect after 3 months from
11/17/08 and paid no brokers commission like they were going
have to pay Empire.
That I assume would be after launch with possibly some revenue
a joint venture or some other good news and an IPO
I see some of the analysts recommending medical stocks that
may do well in an Obama administration dealing with healthcare
maybe we will get some wind beneath our wings.
Regards,
bbhuey
regards,
bbhuey
PatD
Any news on the report as it applies to CTGI market share
regards,
bbhuey
I don't expect to see any news until next year
because it wold not do any good now when everybody
families is going away for the holidays and shopping for
their families
Use this quiet time to position yourselves accordingly
Happy Holidays and all the best to all CTGI longs
bbhuey
a
Steve1
Yes i got there look under coming up shows for Monday-Medical Breakthroughs
There is no contact point or email address
regards,
bbhuey
Montel Williams Show-CBS tv
I was looking at the cbs program TV listing for next week
and saw on Tuesday they will be having a show on
new medical breakthroughs that can be used now such
as camera cs for the eye.
I was trying to figure out how to contact them
but couldn't figure out how to do that.
It would be great if we could get on the show.
and they could talk about Live Tissue Connect.
Regards,
bbhuey
Male1040,
I didn't mean to entice you into buying CTGI today
under unrelated pretenses but it is a low volume day and nobody else is watching
regards,
bbhuey except you
Yikes! My nickel ,copper,gold,palladium.platinum and chrome
Canadian mining stock up 25% plus today from $.42 to $.72.
The last time it did that was when CTGI had a big run to over $2.35.
I don;t know why but these these two stocks seem to like to run up together for some unknown reason
I was collecting $5K a day and the run lasted 5 days I was too stunned to figure out what happened.
I don;t know if that was good stock picking,luck or what.
Maybe we are getting close to something big again it is about time !
regards,
bbhuey
PatD
That is great news.
Appreciate your enthusiasm wish more longs were like you.
In one of the writer's articles he mentioned that his father was a surgeon and that it was always his father's contention
that the faster the body is sutured up after surgery the
least amount of patient complications.It looks like his Dad's
dream has come through with Live Tissue Connnect-Biofuse
technology
Mediligence lists the e company as CSMG Inc.
It seems so obscure any anyone looking at the names
would not know what it is connected to or what it is involved with. cted to
II should be properly listed as d be listed as
CSMG Technogies inc. parent Live Tissue Connect subsidiary -Live Tissue Connect subsidiary that owns
the exclusive rights to this promising technology.
I almost missed it when it was listed like that when I was
going down the list sit of companies covered.
Any thoughts on that.
regards,
bbhuey
Pat D
Thre is an article by Medillligence that they issued called
" Consolidation.competition on the rise in sealant
glue and anti -adhesion market"
where they state that the market for surgical closure and securment is entering a new phase in which the major driving forces are the introduction of new procedures and techniques
by the development of new wound closure devices and bio materials and the willingness of surgeons to use these devices
in the appropriate circumstances
Worldwide medical devices sales have surpassed $173 Billion
in 2006.
In the field of tissue repair and surgical securement
the market reache dalmost $ 7 Billion.
The tissue repair and securement is a benchmark indicator
for overall expansion of medical device usage.
This is becuase surgical closure and securement products are becoming components of surgical procedures
There are over 70 Million procedures worldwide
23 Million are created surgical procdures in the U.S.
There are 3 billion procedures world t receive sealant
products genaerating $1 Billion in sales.
The market potential driven by these volumes is in excess of
$3 Billion for these sealant products for hemostats and sealants and over $1 Billion for skin wound closure using
high strength glue
You can access this by going to gulliver's message and clicking on his link
regards,
bbhuey
of
PatD
Let us know what they think about CTGI
Regards
bbhuey
Gulliver,
Thanks for posting.
I found that Medmarket Diligence who will be coming out
with a new report in December 2008 entitled
Worldwide Sealants,Glues,Wound Closure and Anti-Adhesion Markets for 2009-2013
has CSMG Inc listed under index 4.32
Does anyone get this and have an idea of what they have to say about CSMg ?
Medmarket Diligence is located in foothill Ranch ,California
and can be reached at 949-859-3401
Regards,
bbhuey
Ninja
Thanks,I remmember that also. Nothing else has been submitted since then unless Frank D'Ameio has some new improved designs
that he is developing that we maybe unaware of. ie.cutting and cauterizing and sealing in one instrument
Regards,
bbhuey
Ninja,
Could it be possible that they filed all 8 and the generator
in one filing since they filed allof of these with the Russians for approval?
So far no rejections might be still working on them.
It would be pleasnat surprise to have FDA approval
fordditional applications.
Regards,
bbhuey
Smiles from Within
In this market you have to have faith and a positive attitude
If you don;t believe self doubt can eventually lead to a costly like selling too early at these prices.
With all the bad news in the hopefully you will get your pop
regards,
bbhuey
Ninja,
I was looking at ctgi newsrelease regarding LTC approval
on Russia in 6/27/07 and the start of distribution in
Russia thru the j/v partner Inetrantional Welding Assoication
that didn't seem to happen.I guess pending our 2009
launch.
In the article it mentioned the generator and 8 instruments
and the generator.
In the U.S. they have approval for the generator and 2 instruments
Are the 6 remaining instruments pending? I have not seen anything that indicates that they were filed with the U.S, or the E.U. ? Is there anyway we can find out if there are any pending FDA filings that we may not be aware of?
Regards.
bbhuey
A look at the CSMG international site it indicates that the Ukranians were using the tissue bonding technology to do laparscopic surgery.
This involves cutting a hole the size of a small keyhole incision to get in and work with miniature tools and microscopes to perform surgery.
Does anyone have an idea how our tissue welding technology
would be used in this regard since there are a large number of
these surgeries done in the U.S. every day?
Also what type of approval process LTC would have to do.
Would the approval process be a lot shorter than the previous tools and generator applcaitions?
Anyone know?
Regards,
bbhuey
Ninja,
There is a press release section that announces all of
the new companies announcements that we should focus on
regards,
bbhuey
Ninja,
I was looking at a website that announces and sells used electorsurgical tools and so far we are not mentioned in
their press releases.
It is called dotmed.com
Do you think we should notify Equitrend to put LTC on their
news relase base or do you think we should try to contact
dotmed directly ?
What do you think?
Regards,
bbhuey
I would think that certain events would have to happen
before the choose to offer their IPO in this difficult
market environment.
1.Product for sale-Duct vessel sealing device
2.FDA and EU approval
3.Manufacturing and Development of future products
4.Market acceptance by doctors and hospitals
5.Market acceptance for insurance reimbursement by Medicare
and etc.
6.Training
7.Marketing Plan U.S. and E.U
8.Distribution and Licensing and Joint Venture Plan
9.Actual Launch and Sales Revenues
10. Wall street awareness of company products
I maybe wrong but I think upon actual sales or a marketing deals revenues will help quantify the demand for the LTC
IPO shares and the market price of the actual shares offerred.
which would then affect the CTGI share price.
If they offer IPO LTC prematurely before such sales are in hand then it may have an adverse effect on the value of both LTC and CTGI shares.
Since the market value of the spin out shares of LTC
will hopefully revalue the CTGI shares with some perecnt of thenherent value of the LTC shares that it now holds in the majority.
Don and Frank I thnk are probably driving to meet these goals
Hopefully we are getting close less than a month left for
January 2009 start.
Hope we get a Christmas present
Regards,
bbhuey
If potential an see